复宏汉霖2024年度业绩公告:盈利总额约8.21亿元

财中社
Mar 24, 2025

3月24日,复宏汉霖(02696)发布截至2024年12月31日止年度的年度业绩公告。公司总收入约为57.24亿元,较2023年同期的53.95亿元增加约3.3亿元,增幅为6.1%。该收入主要来自于药物销售、向客户提供的研发服务及授权许可收入。与此同时,公司的研发开支也显著增加,报告期内确认的研发开支约为18.41亿元,较上年同期的14.34亿元增加约4.07亿元,主要由于技术平台创新、IND申报...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10